DOLMETSCH, RICARDO,GASPARINI, FABRIZIO,GOMEZ-MANCILLA, BALTAZAR,JOHNS, DONALD
申请号：
CA3066711
公开号：
CA3066711A1
申请日:
2018.07.30
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of cocaine use by a cocaine use disorder patient； in preventing relapse into cocaine use by a cocaine use disorder patient； in the promotion of cocaine abstinence by a cocaine use disorder patient； in the treatment of the symptoms of depression or anxiety associated with cocaine use disorder.
